Goldman Sachs’s AYTU BioPharma AYTU Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-13,882
| Closed | -$42.2K | – | 4734 |
|
2024
Q1 | $42.2K | Hold |
13,882
| – | – | ﹤0.01% | 4553 |
|
2023
Q4 | $39.4K | Buy |
+13,882
| New | +$39.4K | ﹤0.01% | 4567 |
|
2022
Q2 | – | Sell |
-50,146
| Closed | -$54K | – | 5692 |
|
2022
Q1 | $54K | Buy |
50,146
+9,279
| +23% | +$9.99K | ﹤0.01% | 5453 |
|
2021
Q4 | $55K | Sell |
40,867
-7,726
| -16% | -$10.4K | ﹤0.01% | 5333 |
|
2021
Q3 | $140K | Buy |
48,593
+34,475
| +244% | +$99.3K | ﹤0.01% | 4982 |
|
2021
Q2 | $71K | Sell |
14,118
-63,840
| -82% | -$321K | ﹤0.01% | 5197 |
|
2021
Q1 | $592K | Buy |
+77,958
| New | +$592K | ﹤0.01% | 4244 |
|
2020
Q4 | – | Sell |
-23,160
| Closed | -$28K | – | 4637 |
|
2020
Q3 | $28K | Sell |
23,160
-17,003
| -42% | -$20.6K | ﹤0.01% | 4370 |
|
2020
Q2 | $57K | Sell |
40,163
-20,467
| -34% | -$29K | ﹤0.01% | 4243 |
|
2020
Q1 | $91K | Buy |
+60,630
| New | +$91K | ﹤0.01% | 4183 |
|